Stanley Kim
Chief Executive Officer WinSanTor Inc.
Stanley Kim is the CEO and Co-Founder of WinSanTor, a biotechnology company developing the first disease-modifying therapies for peripheral neuropathy. Previously, he co-founded companies acquired by Qualcomm and Apple and developed technologies now standard in most smartphones. He also served as Director of Intellectual Property at The Salk Institute. Stanley earned his degree in Genetics from the University of California, Berkeley, and later transitioned into law and biotechnology
Seminars
Thursday 26th March 2026
The Rationalization of EAPs for Small Biotech
1:00 pm
- Getting to Phase 3 – The story of WinSantTor
- When Innovation is not always a good thing
- Going from unfundable to a precommercial company in three months
- The difference of Right to Try and Compassionate Use
- Navigating the evolving Expanded Access Programs globally
- How Right to Try will disrupt Innovation for other biotechs
